Phreesia (PHR) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.28
- Estimate
- $0.32
- Surprise
- -14.3%
- Revenue (period 2026-07-31)
- $129.5M
- Score at report (before → after)
- 5.6 → 5.8/10
Revenue source: xbrl.
How the report landed
Phreesia (PHR) missed the $0.32 estimate with diluted EPS of $0.28 — a large 14.3% shortfall. TrendMatrix's engine moved from Buy (Wait) (5.6/10) to Hold at 5.8/10 after the report — the engine's score rose despite the miss.
Coverage in the report window
- DA Davidson Maintains Buy on Phreesia, Lowers Price Target to $13 — benzinga, 2026-09-04
- Baird Maintains Neutral on Phreesia, Raises Price Target to $11 — benzinga, 2026-09-04
- Phreesia Files Shelf Prospectus For Offering; Size Not Disclosed — benzinga, 2026-09-03
Where TrendMatrix's rating stands now
TrendMatrix currently rates PHR Sell at 5.9/10.
1 of the last 4 quarters beat the estimate; this quarter's -14.3% surprise compares with a +5.8% four-quarter average. Next scheduled report: 2026-12-07.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Attractive valuation
What argues against it
- V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3)
- Consecutive earnings misses (2)
- Negative momentum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $10.24
- Price target
- $12.54
- Stop
- $9.72
- Upside to target
- +22.5%
- Reward-to-risk
- 2.6:1
The stock trades at 57.5× trailing but 6.4× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 30 — a level conventionally read as oversold.
Model outputs from TrendMatrix’s engine as of 2026-09-17 — shown for context, not personalized investment advice.
PHR at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Health Information Services
- Market cap
- $642.4M
- P/E (fwd)
- 6.4
- P/E (ttm)
- 57.5
- 52-week range
- $7.77–$25.00
- Off 52-week high
- 59.0%
- RSI (14)
- 30
- Volume vs avg
- 0.74×
- Score today
- 5.9/10